Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Serrano

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
International Journal of Technology Assessment in Health Care|April 23, 2019
The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS)Pedro Serrano-Aguilar, José Asua-Batarrita, María Teresa Molina-López, et al.
Health Policy (Amsterdam, Netherlands)|September 6, 2012
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD studyRenata Linertová, Pedro Serrano-Aguilar, Manuel Posada-de-la-Paz, et al.
BJUI Compass|February 19, 2024
Effectiveness of the T-Control catheter: A study protocolYolanda Ramallo-Fariña, Ana Toledo Chávarri, Adrián Amador Robayna, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2016
Social/economic costs and quality of life in patients with haemophilia in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 11, 2016
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in EuropeMárta Péntek, László Gulácsi, Valentin Brodszky, et al.
Clinical Drug Investigation|December 10, 2014
Early add-on lacosamide in a real-life setting: results of the REALLY studyVicente Villanueva, Mercedes Garcés, Elena López-Gomáriz, et al.
Epilepsia Open|May 7, 2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access ProgramVicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-García, et al.
Epilepsy & Behavior : E&B|November 3, 2022
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsyVicente Villanueva, Adrián García-Ron, Patricia Smeyers, et al.
Heliyon|January 28, 2025
Blood levels of cytokines highlight the role of inflammation in Alzheimer's diseaseLorenzo Campanelli, Pablo Galeano, Federico A Prestia, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
International Journal of Technology Assessment in Health Care|April 23, 2019
The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS)Pedro Serrano-Aguilar, José Asua-Batarrita, María Teresa Molina-López, et al.
Health Policy (Amsterdam, Netherlands)|September 6, 2012
Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD studyRenata Linertová, Pedro Serrano-Aguilar, Manuel Posada-de-la-Paz, et al.
BJUI Compass|February 19, 2024
Effectiveness of the T-Control catheter: A study protocolYolanda Ramallo-Fariña, Ana Toledo Chávarri, Adrián Amador Robayna, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 4, 2016
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2016
Social/economic costs and quality of life in patients with haemophilia in EuropeMarianna Cavazza, Yllka Kodra, Patrizio Armeni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 11, 2016
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in EuropeMárta Péntek, László Gulácsi, Valentin Brodszky, et al.
Clinical Drug Investigation|December 10, 2014
Early add-on lacosamide in a real-life setting: results of the REALLY studyVicente Villanueva, Mercedes Garcés, Elena López-Gomáriz, et al.
Epilepsia Open|May 7, 2023
Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access ProgramVicente Villanueva, Daniel Santos-Carrasco, Pablo Cabezudo-García, et al.
Epilepsy & Behavior : E&B|November 3, 2022
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsyVicente Villanueva, Adrián García-Ron, Patricia Smeyers, et al.
Heliyon|January 28, 2025
Blood levels of cytokines highlight the role of inflammation in Alzheimer's diseaseLorenzo Campanelli, Pablo Galeano, Federico A Prestia, et al.
Pageof 27